Philip Halloran
Affiliations: | University of Alberta, Edmonton, Alberta, Canada |
Area:
Microbiology Biology, ImmunologyGoogle:
"Philip Halloran"Children
Sign in to add trainee| Tasha N. Sims | grad student | 2000 | University of Alberta |
| Lina Kung | grad student | 2001 | University of Alberta |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vietzen H, Döhler B, Tran TH, et al. (2022) Deletion of the Natural Killer Cell Receptor NKG2C Encoding Gene and Kidney Transplant Outcome. Frontiers in Immunology. 13: 829228 |
| Callemeyn J, Lerut E, de Loor H, et al. (2020) Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies. Journal of the American Society of Nephrology : Jasn |
| Kumar D, Raynaud M, Chang J, et al. (2020) Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients With Chronic Active Antibody-mediated Rejection. Transplantation |
| Viglietti D, Lefaucheur C, Philippe A, et al. (2019) FP761NON-HLA AGONISTIC ANTI-ANGIOTENSIN II TYPE 1 RECEPTOR ANTIBODIES INDUCE A DISTINCTIVE PHENOTYPE OF REJECTION IN KIDNEY TRANSPLANT RECIPIENTS: AN OBSERVATIONAL COHORT STUDY Nephrology Dialysis Transplantation. 34 |
| Halloran P, Chang J, Famulski KS. (2018) In Kidney Allografts Inflammation in Scarred Areas is not a Reflection of Chronic Active T Cell-Mediated Rejection Transplantation. 102: S268-S269 |
| Lefaucheur C, Viglietti D, Aubert O, et al. (2018) Anti-angiotensin II type 1-receptor antibodies (AT1R-Ab) Induce a Specific Phenotype of Rejection Distinct from HLA antibody-Mediated Rejection Transplantation. 102: S254 |
| Parkes M, Reeve J, Kim D, et al. (2018) Molecular Assessment of Heart Transplant Biopsies: Emergence of the Injury Dimension Transplantation. 102 |
| Lefaucheur C, Viglietti D, Hidalgo LG, et al. (2017) Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment. Journal of the American Society of Nephrology : Jasn |
| Lefaucheur C, Sis B, Viglietti D, et al. (2017) OR50 Complement-binding donor-specific anti-HLA antibodies induce a specific histo-molecular kidney allograft rejection phenotype Human Immunology. 78: 46 |
| Lefaucheur C, Viglietti D, Mangiola M, et al. (2017) OR12 Complement-binding donor-specific anti-HLA antibodies predict the response to complement-targeting therapy: A multicenter international study Human Immunology. 78: 14 |